You are here » News

News

Entries for 2014

July 02, 2014

Lausanne, July 2, 2014 – Galderma announces that the U.S. FDA granted Orphan Drug Designation status for the company’s trifarotene molecul...

Read more...

Posted in: Press release

June 23, 2014

First Summit on Active Ageing and Healthy Skin Convenes in Manchester, Europe’s Premier Age-friendly City  MANCHESTER, UK (23 June 2014) &...

Read more...

Posted in: News

June 16, 2014

• Latest psychological research reveals rosacea redness creates negative first impressions putting sufferers at a disadvantage • Act on Red...

Read more...

Posted in: Press release

June 02, 2014

This month saw the first edition of a new training program for young dermatologists in China, a partnership initiative between Galderma and the Chines...

Read more...

Posted in: News

May 29, 2014

Galderma positioned to commercialize Restylane®, Perlane®, Emervel®, Sculptra®, Dysport® in the U.S. and Canada ...

Read more...

Posted in: Press release

 3 / 5  

Follow us Follow us on twitter Follow us on Linkedin

Corporate responsibility

Growing a responsible dermatological community

Discover some of the positive initiatives we are involved in across the world

Read

Video

We are committed

See all videos